MALIGNANCY IN MULTINODULAR GOITER-POST THYROIDECTOMY: A PROSPECTIVE STUDY
Objective: To find out the frequency and types of malignancy in patients treated surgically for nontoxic multinodular goiter and its correlation in different age groups and gender. Study Design: Cross-sectional study. Place and Duration of Study: Department of ENT, Combined Military Hospital R...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Army Medical College Rawalpindi
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0f3599fd61af4dabb5dddf56a00a7cbb |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Objective: To find out the frequency and types of malignancy in patients treated surgically for nontoxic
multinodular goiter and its correlation in different age groups and gender.
Study Design: Cross-sectional study.
Place and Duration of Study: Department of ENT, Combined Military Hospital Rawalpindi, from Dec 2018 to
Dec 2019.
Methodology: A total of 116 patients operated for nontoxic multinodular goiter were included in the study.
Demographic details along with pre-op Ultrasonography findings, Fine Needle Aspiration Cytology, thyroid
function test results and post-op histopathological reports of the thyroid specimen were entered on pre-designed proforma. Results were analyzed using the Statistical Package for Social Sciences (SPSS) Version 22.
Results: Age ranges from 19 to 70 years (mean 43.51 years). Out of 116 cases operated for multinodular goiter,
37 (31.8%) had malignant thyroid lesions (13 males, 24 females). Papillary carcinoma of the thyroid (45.9%) was
the commonest malignancy followed by a follicular variant of papillary carcinoma (24.3%). The most common age group with malignancies was 49-58 years.
Conclusion: Malignant Thyroid cancers showed a female preponderance and were most common in age group
49-58 years. Papillary carcinoma of thyroid was the commonest tumor. Radical thyroid surgery is a recommended surgical management option for nontoxic Multinodular goiter. |
|---|